trelstar and Parotid-Neoplasms

trelstar has been researched along with Parotid-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for trelstar and Parotid-Neoplasms

Article	Year
A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:8 Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Nitriles; Parotid Gland; Parotid Neoplasms; Radiotherapy, Adjuvant; Receptors, Androgen; Risk Assessment; Skin Ulcer; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate	2003

Article

Year

A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland.

Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:8

Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Nitriles; Parotid Gland; Parotid Neoplasms; Radiotherapy, Adjuvant; Receptors, Androgen; Risk Assessment; Skin Ulcer; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate

2003